RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Compounds having unique CB1 receptor binding selectivity and methods for their production and use

Compounds having unique CB1 receptor binding selectivity and methods for their production and use

Thomas, B., Seltzman, H., & Francisco, MY. (2004). IPC No. U.S. Compounds having unique CB1 receptor binding selectivity and methods for their production and use. (U.S. Patent No. 6825209).

Abstract

Compounds are provided that are amide analogs of SR141716Ahaving unique CB1 receptor selectivity and providing WIN sparingbinding characteristics, pharmaceutical compositions containing thecompounds and their use in a method of treatment of CB1 receptorrelated disorders, such as obesity, schizophrenia, memorydysfunction and marijuana abuse.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Cannabis use in college
Article

Shared genetic risk between eating disorder- and substance-use-related phenotypes
Article

Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism
OCCASIONAL PAPER

Agreements between public health organizations and food and beverage companies